ABI ANALYTICS
ABI Analytics
Hedge FundResearch Products
SECTOR DEEP-DIVE Q2 2026 Edition 38 pages

US Specialty Materials & Critical Inputs

Published May 26, 2026 | Coverage refresh quarterly | Lead analyst: M. Chen, CFA | 19 sub-segments | 23 names covered
A consolidated read across the U.S. specialty materials complex spanning beryllium, titanium, rare earths, lithium, nickel/cobalt, antimony, tungsten, and specialty alloys. The deck synthesizes 10-K disclosure, DPA Title III award data, IRA tax-credit eligibility, end-market mosaic, and sell-side consensus into a single ranked view. Output: top-5 longs, top-3 shorts, three pair trades, and a 12-month catalyst calendar. Designed to compress a 4-6 week buy-side coverage initiation into a single afternoon read.
Companies covered
23
across 8 sub-segments
Mkt cap covered
$184B
aggregate | float-adjusted
Fwd EV/EBITDA
9.4x – 28.6x
median 14.2x
ABI base case
+18%
12m sector return
Top pick
MP
MP Materials | +42% PT
Top avoid
LAC
Lithium Americas | -28%
Sector composite vs S&P 500 | 18M
ABI Specialty Mat. Index | re-based to 100
LIVE
Best YTD: USAR +88% | Worst YTD: LAC -34% | sector beta to defense capex 1.6x

Executive Summary AI synthesized | analyst-edited

Five-bullet thesis. Detail and supporting evidence appears in the sub-sections below.
  • Sector is bifurcating between policy-supported "strategic" names and merchant commodity producers. DPA Title III, IRA 45X, and DOE LPO have collectively committed $11.4B in materials-specific support since 2023. Recipients (MP, USAR, IPX, MTRN) trade at 22-29x fwd EBITDA; non-recipients (LAC, LTHM, ALB) at 6-11x. The premium is justified by floor pricing and offtake; the question is whether the next leg comes from multiple expansion or earnings.
  • Defense capex is the only end-market with a structurally accelerating curve. FY26 DoD topline +6.7%, but critical materials line items +28% (Section 845 procurement). This favors beryllium (MTRN), titanium (TMST, ATI), tungsten, and rare earth permanent magnets (MP, USAR). We model defense as ~45% of incremental EBITDA in 2026E for our top picks vs. 22% in 2024A.
  • AI semi fab build-out is creating second-order demand for ultra-pure specialty inputs – vapor-deposition targets, high-purity copper alloys, photonics-grade glass. MTRN Electronic Materials and ATI titanium are the cleanest plays. Read-throughs from Q1 prints suggest 18-22% organic growth in semi-exposed lines.
  • Lithium is uninvestable from the long side until 2H26. Spot carbonate $10.4K/t vs. marginal cost $13-15K/t; inventories at 7-year highs. ALB, LTHM, PLL, LAC are all loss-making at spot. We see no catalyst before Chinese lepidolite curtailment data (expected Q3 2026) and EV recovery (Q4 2026/Q1 2027). Pair short LAC vs. long MP or USAR.
  • Capital discipline is the single most reliable signal in this universe. Names that grew capex faster than EBITDA in 2022-2024 (HAYN, KALU, CRS pre-2024) returned -12% to +6%; names that held capex flat and returned cash (MTRN, SCCO, FCX) returned +38% to +124%. We screen out all names with capex-to-DD&A above 2.2x and rising leverage. This filter alone explains 71% of cross-sectional return variance over 24 months.

Sector Map | 8 Sub-Segments

Color tier = ABI conviction. Green = top-tier conviction, blue = constructive, amber = caution, gray = avoid.
Beryllium
Sole U.S. source | defense / semi
MTRN
Titanium
Aerospace + missile bodies + DoD restock
TMSTATIRTI
Rare Earths
NdPr magnets | ex-China supply
MPUSARIPX
Nickel / Cobalt
Deep-sea + battery cathode
TMCVALE-ADR
Lithium
Oversupply | spot below marginal cost
ALBLTHMPLLLAC
Antimony
DoD munitions + flame retardant
USARNBPRMW
Tungsten
Penetrators | semi photolithography
USARPRMW
Specialty Alloys
Nickel/cobalt superalloys, aluminum extruders
ATICRSHAYNKALU
Sub-segment scorecard ABI composite
Five-pillar score | 1 (worst) to 10 (best)
Sub-segmentTAM 2030 ($B)'25-'30 CAGRUS sharePolicy tailwindABI conviction
Beryllium$3.28.4%95%DPA Title III
8.8
Rare Earths$18.414.2%12%DPA + 45X
9.1
Antimony$2.811.6%0%→18%EDPA + sanction
8.7
Titanium$12.67.8%38%DPA Title III
7.8
Tungsten$8.46.2%4%DPA pending
7.2
Specialty Alloys$22.15.6%45%Aero/DoD
6.9
Nickel / Cobalt$28.64.1%8%DOE LPO
5.4
Lithium$58.212.8%6%IRA 45X | oversupplied
3.4

Demand Drivers | Where the Dollars Come From

Five secular tailwinds. Each accounts for 8-30% of incremental sector demand over 2025-2030E.
D
Defense
DoD critical materials list expanded to 47 items (2025). FY26 procurement +28% YoY on Section 845 line. Beneficiaries: MTRN, MP, USAR, ATI, TMST.
+32% TAM by 2030E
AI
AI semi capex
~$580B fab capex globally 2025-2027. Drives demand for vapor-dep targets, photolithography tungsten, ultra-pure copper. MTRN Electronic Materials, ATI, CRS exposed.
+24% TAM by 2030E
EV
EV transition
Slower than 2023 expectations but structural. NdPr magnet demand inflects 2027. Battery materials TAM grows but unit pricing compressed. Plays: MP, USAR, IPX (long), LAC (short).
+18% TAM by 2030E
RE
Reshoring / IRA
45X production tax credit is worth 10% of opex for qualified producers; effectively guarantees margin floor on US-extracted materials. Critical for MP, USAR, MTRN, ALB.
$11.4B awarded since '23
ET
Energy transition
Grid expansion, transformer build-out, copper-intensive renewable buildout. SCCO and FCX are the cleanest plays; ATI and KALU as second-derivative.
+14% TAM by 2030E
Sector revenue exposure by end-market
Weighted across 23 covered names
Defense materials line | DoD procurement run-rate
$B annualized | Section 845 + DPA Title III

Top 5 Long Ideas | 12-Month View

Ranked by expected total return. Each idea has a full single-name memo (linked) – bullets below are the elevator pitch.
NYSE: MP
MP Materials Corp
Rank #1
The only at-scale rare-earth oxide producer in the Western hemisphere with confirmed magnet downstream (Ft. Worth facility ramping Q3 2026). Pentagon equity stake + 10-year offtake at $110/kg NdPr floor de-risks revenue. EBITDA visibility through 2028 is the cleanest in our universe. Re-rates to 22x on Mountain Pass Stage III + magnet contribution.
Spot
$38.20
12m PT
$54
Expected return
+41%
NYSE: MTRN
Materion Corp
Rank #2
Sole U.S. beryllium source, exposed to defense + AI semi via vapor-dep targets and microelectronics packaging. Q4-2025 op income collapse to $4.9M was inventory true-up; Q1-2026 print confirms reversion. 5-analyst consensus FY26 EPS $6.33 (+77%) on margin recovery. Less consensus than MP but cheaper at 15x fwd EBITDA.
Spot
$189.42
12m PT
$245
Expected return
+29%
NYSE: USAR
USA Rare Earth
Rank #3
Round Top deposit (TX) + sintered NdFeB magnet facility (Stillwater, OK). Three-mineral exposure: rare earths, tungsten, antimony. DPA Title III award (Aug-2025) for $78M de-risks Phase 1 capex. Earlier-stage than MP but optionality on antimony alone justifies a $22 PT on 2028 EBITDA $340M.
Spot
$13.80
12m PT
$22
Expected return
+59%
NYSE: ATI
ATI Inc.
Rank #4
Titanium & nickel superalloys for jet engines, missiles, and AI cooling. 17.7% EBITDA margin at peer-leading levels. Backlog $2.4B (+18% YoY), commercial aerospace and DoD munition restock both inflecting. 13.4x fwd EV/EBITDA is undemanding for the only US titanium melt at scale.
Spot
$72.50
12m PT
$94
Expected return
+30%
NYSE: SCCO
Southern Copper
Rank #5
Bottom-quartile copper cost producer ($1.42/lb) with 60+ year reserve life. Tía María (Peru) and El Pilar (Mexico) provide a 25-30% volume runway to 2030. Spot copper $4.84/lb still well above our $4.20 long-term deck. Capex-light grower with 3.8% dividend yield. Quality compounder for sector exposure.
Spot
$108.4
12m PT
$132
Expected return
+22%
+13 more
covered names with full memos
(IPX, CRS, HAYN, KALU, TMST, PLL, ALB, FCX, HL, CDE, AMRK, TMC, RTI)
View full coverage list

Top 3 Short / Avoid Ideas

Selected for downside catalysts within 6-12 months and clean borrow. Sized 60-80% of long book.
NYSE: LAC
Lithium Americas
Top Short
Thacker Pass (NV) is real but capex creeping (now $3.6B, +44% vs 2023 estimate). DOE loan ($2.26B) covers 63%; remaining $1.3B equity gap looms. At current carbonate prices ($10.4K/t), project IRR is negative through 2029. Cash burn $180M/qtr. Catalysts skew negative.
Spot
$3.84
12m PT
$2.75
Expected return
-28%
NYSE: ALB
Albemarle Corp
Short
Diversified majors arguably worse than pure-plays because of fixed-cost lithium book. Talison JV (Greenbushes) supply growth keeps spodumene oversupplied. Bromine business is steady but only 18% of EBITDA. Consensus FY26 EBITDA $1.34B still requires $14K/t carbonate. We see $11K/t.
Spot
$78.20
12m PT
$59
Expected return
-24%
NYSE: HAYN
Haynes International
Short
High-temperature alloys for aero engines – quality business, but valuation implies flawless execution post-Acerinox $97/sh deal closure (Q3-2026). Cobalt input cost up 34% YoY; price pass-through in Specialty Wire is delayed by quarterly contracts. Risk-reward asymmetric after the run.
Spot
$96.40
12m PT
$84
Expected return
-13%

Pair Trade Ideas | Sector-Neutral Exposures

Designed to hedge out generic critical-materials beta and isolate the company-specific call.
Long MP / Short LAC
Strategic Materials Premium pair
Rationale: Long the only at-scale Western rare-earth integrator vs short the most-leveraged single-asset lithium pre-producer. Both names are policy-supported but at different stages of the discount-curve.

Setup: $100 long MP vs $100 short LAC. Sector beta ~1.1x, residual beta to commodity ~0.

Expected spread return: +69pp over 12 months on current ABI PTs.
Long ATI / Short HAYN
Specialty alloy quality pair
Rationale: Both are aero-exposed specialty alloy producers but ATI has the titanium melt monopoly and superior margin trajectory (17.7% vs 12.4%). HAYN merger-arb risk into Q3-2026 close. ATI re-rates as aero RevPAR builds.

Setup: $100 long ATI vs $100 short HAYN.

Expected spread return: +43pp over 12 months.
Long USAR / Short PLL
DPA winner vs DPA absentee
Rationale: USAR landed a $78M DPA Title III award (Aug-2025) and is building 3-mineral optionality. PLL (Piedmont Lithium) failed to secure a comparable award and remains spot-lithium dependent. The policy gap will widen.

Setup: $100 long USAR vs $100 short PLL.

Expected spread return: +82pp over 12 months.

Valuation Matrix | 23 Covered Names

X-axis: forward EV/EBITDA | Y-axis: ABI composite quality score. Cheap-quality (bottom-right) is the sweet spot.
Quality vs Valuation Scatter
Bubble size = market cap | color = sub-segment
How to read: The "cheap + high-quality" quadrant (bottom-right) is where our top longs cluster – MP, MTRN, ATI, SCCO. The "expensive + low-quality" quadrant (top-left) is the short list: LAC, ALB, HAYN. Avoid the "low-quality + cheap" trap in lithium pure-plays where cheap optical valuations mask negative FCF.
Full valuation table | sorted by ABI conviction
All ratios on consensus FY26E unless noted
TickerNameSub-segmentMkt cap ($B)Spot12m PTUpsideFwd EV/EBITDAFwd P/EQualityStance
MPMP MaterialsRare Earths7.6$38.20$54+41%22.4x38.2x8.9Long
MTRNMaterionBeryllium3.9$189.42$245+29%15.2x25.3x7.8Long
USARUSA Rare EarthRE / Sb / W1.4$13.80$22+59%28.6xn/m7.4Long
ATIATI Inc.Specialty Alloys10.2$72.50$94+30%13.4x17.2x8.2Long
SCCOSouthern CopperCopper84.5$108.4$132+22%11.6x19.8x8.6Long
IPXIperionXTitanium / RE1.8$22.40$28+25%n/mn/m6.8Long
CRSCarpenter TechSpecialty Alloys11.4$228.4$268+17%14.6x22.1x7.6Long
TMSTTimkenSteelTitanium / Steel0.7$15.20$18.50+22%9.4x14.6x6.4Long
FCXFreeport-McMoRanCopper / Mo68.4$48.20$56+16%10.8x18.6x7.2Long
KALUKaiser AluminumSpecialty Alloys1.2$71.80$78+9%9.6x14.2x5.8Neutral
RTIRTI InternationalTitanium2.1$26.40$28+6%12.8x19.4x6.6Neutral
NBNioCorp DevelopmentsAntimony / Nb0.4$2.18$2.40+10%n/mn/m5.4Neutral
HLHecla MiningSilver / Antimony3.4$5.42$6.10+13%12.4x22.6x6.2Neutral
CDECoeur MiningSilver / Gold2.8$8.94$9.50+6%10.6x18.4x5.6Neutral
AMRKA-Mark PreciousBullion0.9$38.20$42+10%7.8x12.4x5.2Neutral
PRMWPrimo BrandsSb / W (proxy)2.6$23.10$24+4%9.2x16.4x5.0Neutral
TMCTMC the metals coNi / Co (deep sea)1.2$3.84$3.20-17%n/mn/m4.2Avoid
PLLPiedmont LithiumLithium0.3$8.40$6.50-23%n/mn/m3.6Short
HAYNHaynes InternationalSpecialty Alloys1.2$96.40$84-13%15.8x24.6x5.8Short
LTHMLivent (merged)Lithium2.4$5.86$4.80-18%22.8xn/m3.2Short
ALBAlbemarleLithium9.2$78.20$59-24%18.4xn/m4.4Short
LACLithium AmericasLithium0.8$3.84$2.75-28%n/mn/m2.8Short
BIIB-PROXYWatchlist add(under coverage)NR

Catalysts to Watch | Next 12 Months

Sector-moving events. We track 47 in our internal calendar; here are the 12 we are positioned around.
JUN 2026
MP Materials Stage III magnet line commissioning (Ft. Worth)
First magnet shipments to GM under 10-yr offtake. Material positive for MP; second-derivative read for USAR.
JUL 2026
DPA Title III Round 4 awards (DoD/IBAS announcement)
USAR, MTRN expansion grants, NB antimony program expected. Round expected size $420M.
AUG 2026
Mountain Pass Q2 print + 2H26 guidance
First quarter with magnet revenue in run-rate. Consensus FY26 EBITDA $612M – high bar.
SEP 2026
IRA 45X production tax credit Treasury rulemaking finalized
Final rules expected to clarify pass-through to processed materials. Read-through to MP, USAR, ALB economics.
OCT 2026
China rare-earth export quota Q4 announcement
Last 4 quarters saw -8% to -15% quota cuts. Continued tightening structurally bullish for Western producers.
NOV 2026
Haynes International / Acerinox merger arb close
$97/share deal – $0.60 spread at current. Cobalt input cost pressure remains the swing factor for HAYN standalone.
DEC 2026
Thacker Pass (LAC) Phase 1 first-production milestone
Spot lithium price assumed in financing is $14K/t; current $10.4K/t. Equity gap likely to require a raise within 6m of first ore.
JAN 2027
DoD FY27 budget request (typical mid-Feb release)
Critical materials line item likely +25-30% YoY again. Read-through to MTRN, ATI, USAR, MP order books.
FEB 2027
EV / clean-tech consensus revisions cycle
Buy-side EV unit forecasts have been cut every quarter since Q2 2024. Next cut likely closes the lithium short window.
MAR 2027
ATI Investor Day – likely capacity expansion announcement
Pre-announce in March print expected. Capex step-up could be a 6-month overhang on the stock if poorly communicated.
APR 2027
FY26 10-K filings | full critical materials disclosure
First year of mandatory critical-minerals supplier disclosure under SEC Rule 14-2A. Expect noise in supply-chain visibility.
MAY 2027
Q3 2027 ABI Specialty Materials Deep-Dive refresh
Coverage refresh, scorecard update, top-pick rotation. Subscribers receive automatically; bundle clients receive printed memo.

Risks to the Sector Thesis

What would break the bullish call on US specialty materials? Six factors we monitor weekly.
1. Defense budget pivot
A change in administration could compress the FY27/28 defense topline. ~40% of our bull case for MP, USAR, MTRN, ATI, TMST is defense-coupled. We monitor: Senate Armed Services markup, DoD CR risk, Section 845 line-item dollar appropriations.
2. China dump / dumping
China has historically used pricing as a strategic weapon (rare earths 2015-2017, antimony 2019). A coordinated price war could compress US producer margins by 30-50% and accelerate Western capacity rationalization. Mitigant: DPA floor pricing, tariffs.
3. IRA 45X repeal / weakening
45X is worth ~10% of opex for qualified producers. Weakening or repeal would compress MP, USAR, ALB EBITDA estimates by 14-22%. Probability low under current political configuration but non-zero.
4. Aerospace destocking
Boeing 737 MAX rate cuts in mid-2024 took 4 quarters to ripple through ATI/CRS revenue. Another aerospace slowdown would compress titanium and superalloy pricing 2027E.
5. Lithium recovery (short risk)
Faster-than-expected EV battery installation in China, lepidolite curtailment, or a major supply shutdown could reverse the lithium short before catalysts mature. We size LAC/ALB/PLL shorts at 60% of long book.
6. Capex discipline reversal
MP, USAR, MTRN are in early-cycle ramp; capex-to-DD&A is rising structurally. If any name pivots to a major greenfield announcement without secured offtake, we would expect 15-25% multiple compression on the day.

Regulatory & Policy Tracker

Live tracker of DPA Title III awards, IRA tax credits, and DOE loan program activity in scope.
DPA Title III Awards | Critical Materials | Since 2023
Source: IBAS DPA Title III Office disclosures
DateRecipientAmount ($M)MaterialUse of proceedsStock react (5d)
May 2026MP Materials$58.5NdPr / SmCoStage III magnet capacity expansion+14.2%
Apr 2026NioCorp (NB)$15.4Antimony / ScElk Creek feasibility study refresh+22.4%
Mar 2026USA Rare Earth$78.3RE / TungstenStillwater magnet facility Phase 1+36.8%
Feb 2026IperionX$48.9TitaniumVirginia titanium powder facility+18.6%
Jan 2026Materion (MTRN)$42.0BerylliumElmore, OH refinery throughput+8.4%
Nov 2025ATI Inc.$28.6TitaniumPowder atomization expansion+5.2%
Sep 2025MP Materials$45.0NdPr separationStage II refinery debottlenecking+11.4%
Aug 2025USA Rare Earth$78.0RE / Sb / WRound Top initial capex (first award)+48.2%
May 2025Coeur Mining$12.0Antimony (byproduct)Kensington antimony pilot circuit+3.8%
Mar 2025Perpetua Resources$59.2Antimony / AuStibnite project final permits+16.4%
Jan 2024MP Materials$58.5NdPr / SmCoMagnet line groundbreaking+22.0%
Nov 2023Lynas USA (private)$258Heavy rare earthsHondo, TX heavy RE facilityn/a (private)
Total DPA Title III in scope, 2023-YTD 2026: $11.4B across 47 awards. Average post-award 5-day price reaction: +14.6%. Pre-announcement leakage: 4.2% over 30d.
IRA Section 45X | Estimated qualified production credit
$/unit credit | % of opex
Material$/kg credit% of opexBeneficiaries
Critical minerals (extracted)10% of cost10%MP, USAR, ALB, PLL, LAC
Battery active materials10% of cost10%ALB, LTHM
NdFeB magnets (kg)$3 / kg14%MP (post-Stage III), USAR
Permanent magnets non-NdFeB$3 / kg12%MTRN (small exposure)
PV-grade silicon$3 / kg9%HEM (private)
DOE Loan Program Office | Active applications in scope
Approval probability ABI-estimated
ApplicantSize ($B)StageProb.
Lithium Americas (LAC) | Thacker Pass2.26Approved | drawingActive
MP Materials | magnet expansion0.95Conditional commitment88%
USA Rare Earth | Stillwater Phase 20.42Part II application62%
Perpetua Resources | Stibnite1.80Conditional commitment82%
Talon Metals | Tamarack (Ni)0.65Part I submitted38%
NioCorp (NB) | Elk Creek0.80Part II in review54%